FDA Approves Genentech’s Vabysmo to Treat Wet Age-Related Macular Degeneration, Diabetic Macular Edema, and Macular Edema Due to Retinal Vein Occlusion

The Vabysmo prefilled syringe is designed to simplify administration for retinal specialists and improve the treatment experience for both physicians and patients with wet age-related macular degeneration, diabetic macular edema and macular edema associated with retinal vein occlusion.